Vestibular rehabilitation was found to ameliorate headache, dizziness, and psychological factors in patients with vestibular migraine or a combination of tension-type headache and dizziness.
In a phase 3 trial, treatment with erenumab reduced migraine frequency, monthly migraine days, and migraine medication use in patients with episodic migraine.
The risk for developing hypertension was slightly higher in women with a history of migraine compared with women who do not have a history of the condition.
The presence of headache may be correlated with PTSD severity.
Acute migraine attacks are associated with a reduction in dopamine release.
FDA grants 2 supplemental New Drug Applications for Qudexy XR capsules for use as prophylaxis of migraine headache.
Both patients with migraine and migraine-free control patients with photophobia were found to exhibit higher rates of depression, anxiety, and stress than individuals without photophobia.
Psychological factors such as catastrophizing of pain are common in migraine and, along with depression and anxiety, contribute significantly to migraine-related disability.
Higher levels of pain acceptance were associated with less headache disability and pain interference in overweight women with migraine.
Remote electrical stimulation is an effective, noninvasive, nonpharmacologic alternative treatment to traditional medications for acute migraine.
While it requires further validation, copeptin may serve as a novel biomarker to help rule out serious secondary headache.
Clinical Pain Advisor Articles
- Transcranial Random Noise Stimulation Effective on Multiple Fibromyalgia-Associated Symptoms
- Comparing Dry Needling, Cortisone for Greater Trochanteric Pain Syndrome
- Vestibular Rehabilitation an Effective Treatment for Vestibular Migraine
- Secondary Hyperalgesia Mediated by Nociceptive and Other Sensory Pathways
- Naloxone: Policies and Access